Copyright
©The Author(s) 2023.
World J Gastroenterol. Jan 14, 2023; 29(2): 286-309
Published online Jan 14, 2023. doi: 10.3748/wjg.v29.i2.286
Published online Jan 14, 2023. doi: 10.3748/wjg.v29.i2.286
Figure 1 Risk factors for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis -associated hepatocellular carcinoma.
HCC: Hepatocellular carcinoma; NAFLD: Nonalcoholic fatty liver disease; NASH: Non-alcoholic steatohepatitis; T2DM: Type 2 diabetes mellitus.
- Citation: Cernea S, Onișor D. Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma. World J Gastroenterol 2023; 29(2): 286-309
- URL: https://www.wjgnet.com/1007-9327/full/v29/i2/286.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i2.286